Peter Mack, PhD

Linkedin Team icon

VP, Pharmaceutical Development

Peter Mack, PhD joined MindMed from AstraZeneca, most recently as Director of Manufacturing, where he led functional and matrix teams in Pharmaceutical Technology and Development resulting in successful Phase 3 development and global marketing application approval of two commercial products – Bevespi Aerosphere ® and Breztri Aerosphere ®. Peter previously worked at Pearl Therapeutics (acquired by AstraZeneca in 2013) and Liquidia Technologies, where he helped pioneer the development of novel inhaled therapies for highly prevalent respiratory diseases. Peter holds a dual PhD in Medical Engineering and Medical Physics from Harvard Medical School and Massachusetts Institute of Technology (MIT), where he was a National Institute of Health (NIH) Biomechanics Training Grant Recipient. Peter also holds a Masters of Science in Mechanical Engineering from MIT and a Bachelors of Science in Mechanical Engineering from the University of Notre Dame. During his time in academia and the pharmaceutical industry, Peter has contributed to numerous peer reviewed articles and patents.
Robert Barrow Portrait

Robert Barrow

Chief Executive Officer and Board Director

Miri Halperin Wernli, PhD Portrait

Miri Halperin Wernli, PhD

Executive President and Board Director

Cynthia Hu, JD Portrait

Cynthia Hu, JD

Chief Legal Officer & Corporate Secretary

Daniel Karlin, MD, MA Portrait

Daniel Karlin, MD, MA

Chief Medical Officer

Schond Greenway, MBA Portrait

Schond Greenway, MBA

Chief Financial Officer

Francois Lilienthal, MD, MBA Portrait

Francois Lilienthal, MD, MBA

Chief Commercial Officer

Robert Silva, PhD Portrait

Robert Silva, PhD

VP, Head of Development

Robert Malenka, MD, PhD Portrait

Robert Malenka, MD, PhD

Chairman of the Scientific Advisory Board, Nancy Friend Pritzker Professor in Psychiatry and Behavioral Sciences at Stanford University

Peter Bergethon, MD Portrait

Peter Bergethon, MD

Member, Scientific Advisory Board VP, Head of Quantitative & Clinical Technologies, Biogen, Inc.

Robert Dworkin, PhD Portrait

Robert Dworkin, PhD

Professor of Anesthesiology and Perioperative Medicine, Neurology, and Psychiatry at University of Rochester

Maurizio Fava, MD Portrait

Maurizio Fava, MD

Psychiatrist-in-Chief of the Massachusetts General Hospital (MGH)

Maria Oquendo, MD, PhD Portrait

Maria Oquendo, MD, PhD

Ruth Meltzer Professor and Chairman of Psychiatry at University of Pennsylvania, Psychiatrist-in-Chief at the Hospital of the University of Pennsylvania

Bridget Walton, MS Portrait

Bridget Walton, MS

VP, Global Regulatory Affairs

Kenneth Alper, MD Portrait

Kenneth Alper, MD

Clinical Associate Professor of Psychiatry and Neurology at the New York University School of Medicine

Peter Gasser, MD Portrait

Peter Gasser, MD

Clinical Advisor

Stanley D Glick, MD PhD Portrait

Stanley D Glick, MD PhD

Scientific Advisor

Matthew W Johnson, PhD Portrait

Matthew W Johnson, PhD

Clinical Advisor

Kim PC Kuypers, PhD Portrait

Kim PC Kuypers, PhD

Scientific Collaborator & Advisor

Matthias Liechti, MD, PhD Portrait

Matthias Liechti, MD, PhD

Scientific Collaborator & Advisor

Carol Vallone Portrait

Carol Vallone

Chair of the Board of Directors, Chair of Compensation Committee, Member of Audit/Finance Committee

Natalie Wheeler, PhD Portrait

Natalie Wheeler, PhD

Medical Science Liaison with Dova Pharmaceuticals

John Rotrosen, MD Portrait

John Rotrosen, MD

Professor of Psychiatry with New York University’s Langone’s Department of Psychiatry

Andreas Krebs Portrait

Andreas Krebs

Vice Chair of the Board of Directors, Chair of Nomination and Governance Committee, Member of Audit/Finance Committee

Brigid Makes Portrait

Brigid Makes

Board Director, Chair of Audit/Finance Committee, Member of Compensation Committee, Member of Nomination and Governance Committee

Carrie Liao, CPA Portrait

Carrie Liao, CPA

VP, Corporate Controller & Principal Accounting Officer

Peter Mack, PhD Portrait

Peter Mack, PhD

VP, Pharmaceutical Development

Carole Abel, MBA Portrait

Carole Abel, MBA

VP, Programs and Portfolio Office (PPO)